Analyst Ratings for Black Diamond Therapeutics (BDTX)
BDTX Rating Summary
BDTX Price Target Summary
- Highest: $11.00 (H.C. Wainwright)
- Lowest: $7.00 (Freedom Capital)
- Average: $9.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$9.00 (+405.6%)
* Over Last 12-Mos
Rating Score: 9.1 / 10
Percentile Rank: 89%
Avg. $ Target:
$9.00 (+405.6%)
* Over Last 12-Mos
Rating Score: 9.1 / 10
Percentile Rank: 89%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/3/2025 | Guggenheim | Bradley Canino | Downgrade | Neutral (Buy) |
N/A (N/A) |
3.45 (1.78) |
-48.41% | Details |
| 11/17/2025 | Piper Sandler » Updated 1/16/2026 |
Kelsey Goodwin | New Coverage | Overweight (N/A) |
8.00 (9.00) |
4.01 (1.78) |
-55.61% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
